These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 12439646)

  • 21. The effect of a six-month exercise program on very low-density lipoprotein apolipoprotein B secretion in type 2 diabetes.
    Alam S; Stolinski M; Pentecost C; Boroujerdi MA; Jones RH; Sonksen PH; Umpleby AM
    J Clin Endocrinol Metab; 2004 Feb; 89(2):688-94. PubMed ID: 14764782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism.
    Chan DC; Nguyen MN; Watts GF; Barrett PH
    J Clin Endocrinol Metab; 2008 Feb; 93(2):557-64. PubMed ID: 18000086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism. Studies before and after sulfonylurea therapy.
    Taskinen MR; Beltz WF; Harper I; Fields RM; Schonfeld G; Grundy SM; Howard BV
    Diabetes; 1986 Nov; 35(11):1268-77. PubMed ID: 3530855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adiponectin is an important determinant of apoA-I catabolism.
    Vergès B; Petit JM; Duvillard L; Dautin G; Florentin E; Galland F; Gambert P
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1364-9. PubMed ID: 16574896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in lipoprotein kinetics associated with type 2 diabetes affect the distribution of lipopolysaccharides among lipoproteins.
    Vergès B; Duvillard L; Lagrost L; Vachoux C; Garret C; Bouyer K; Courtney M; Pomié C; Burcelin R
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1245-53. PubMed ID: 24694333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omega-3 fatty acid ethyl ester supplementation decreases very-low-density lipoprotein triacylglycerol secretion in obese men.
    Wong AT; Chan DC; Ooi EM; Ng TW; Watts GF; Barrett PH
    Clin Sci (Lond); 2013 Mar; 125(1):45-51. PubMed ID: 23356247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicotinic acid decreases apolipoprotein B100-containing lipoprotein levels by reducing hepatic very low density lipoprotein secretion through a possible diacylglycerol acyltransferase 2 inhibition in obese dogs.
    Le Bloc'h J; Leray V; Chetiveaux M; Freuchet B; Magot T; Krempf M; Nguyen P; Ouguerram K
    J Pharmacol Exp Ther; 2010 Aug; 334(2):583-9. PubMed ID: 20442223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fat compartments and apolipoprotein B-100 kinetics in overweight-obese men.
    Watts GF; Chan DC; Barrett PH; Susekov AV; Hua J; Song S
    Obes Res; 2003 Jan; 11(1):152-9. PubMed ID: 12529498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of body weight on insulin activity].
    Sindelka G; Skrha J; Prázný M; Hilgertová J
    Vnitr Lek; 1999 Sep; 45(9):540-4. PubMed ID: 10951879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
    Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VLDL (Very-Low-Density Lipoprotein)-Apo E (Apolipoprotein E) May Influence Lp(a) (Lipoprotein [a]) Synthesis or Assembly.
    Croyal M; Blanchard V; Ouguerram K; Chétiveaux M; Cabioch L; Moyon T; Billon-Crossouard S; Aguesse A; Bernardeau K; Le May C; Flet L; Lambert G; Hadjadj S; Cariou B; Krempf M; Nobécourt-Dupuy E
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):819-829. PubMed ID: 32078365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL.
    Golay A; Zech L; Shi MZ; Chiou YA; Reaven GM; Chen YD
    J Clin Endocrinol Metab; 1987 Sep; 65(3):512-8. PubMed ID: 3114304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin and lipoprotein metabolism with special reference to the diabetic state.
    Tomkin GH; Owens D
    Diabetes Metab Rev; 1994 Oct; 10(3):225-52. PubMed ID: 7835171
    [No Abstract]   [Full Text] [Related]  

  • 34. Relationships between the metabolism of high-density and very-low-density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity.
    Magill P; Rao SN; Miller NE; Nicoll A; Brunzell J; St Hilaire J; Lewis B
    Eur J Clin Invest; 1982 Apr; 12(2):113-20. PubMed ID: 6807682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects.
    Corsetti JP; Sparks CE; Bakker SJL; Gruppen EG; Dullaart RPF
    Clin Biochem; 2018 Feb; 52():67-72. PubMed ID: 29157655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase.
    Jeong Ts; Schissel SL; Tabas I; Pownall HJ; Tall AR; Jiang X
    J Clin Invest; 1998 Feb; 101(4):905-12. PubMed ID: 9466986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma phospholipid transfer protein activity is independently determined by obesity and insulin resistance in non-diabetic subjects.
    de Vries R; Kappelle PJ; Dallinga-Thie GM; Dullaart RP
    Atherosclerosis; 2011 Jul; 217(1):253-9. PubMed ID: 21481395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study of the metabolism of apolipoprotein B100 in relation to insulin resistance in African American males.
    Sumner AE; Falkner B; Diffenderfer MR; Barrett PH; Marsh JB
    Proc Soc Exp Biol Med; 1999 Sep; 221(4):352-60. PubMed ID: 10460697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal Obesity.
    Vergès B; Adiels M; Boren J; Barrett PH; Watts GF; Chan D; Duvillard L; Söderlund S; Matikainen N; Kahri J; Lundbom N; Lundbom J; Hakkarainen A; Aho S; Simoneau-Robin I; Taskinen MR
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1398-406. PubMed ID: 26835543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atorvastatin plus omega-3 fatty acid ethyl ester decreases very-low-density lipoprotein triglyceride production in insulin resistant obese men.
    Ng TW; Ooi EM; Watts GF; Chan DC; Barrett PH
    Diabetes Obes Metab; 2014 Jun; 16(6):519-26. PubMed ID: 24299019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.